Find Academic Supervisors

Jae Eun Chung is a Professor in the Department of Communication Studies at Howard University's School of Communications. Her research focuses on new media technologies, their psychosocial impacts, and health communication, with a particular emphasis on community engagement and digital discourse. Ph.D. in Communication from the University of Southern California M.A. in Telecommunications from Indiana University at Bloomington Dr. Chung's work explores the intersection of social media and health, analyzing how digital platforms influence public health perceptions, patient-doctor interactions, and health equity. She has published extensively in journals like Journal of Communication , Computers in Human Behavior , and Health Communication , often employing community-based participatory research (CBPR) to address disparities in asthma care, maternal health, and HPV-associated cancer awareness. Recent publications highlight trends in leveraging social media for health interventions, examining misinformation dynamics during crises like the COVID-19 pandemic, and analyzing digital ecosystems. Her methodological approaches include network analysis, narrative studies, and assessments of digital engagement metrics. Howard University RCMI Grant: Enhancing recruitment of African-Americans and Hispanics in health research NSF HDR Grant: Collaborative research on data analytics for community enrichment PACRI Grant: Improving health outcomes for asthmatic children in public housing Bezos Earth Fund: Indoor environmental quality disparities in underserved communities Dr. Chung collaborates with interdisciplinary teams, including public health experts and data scientists, to advance health communication strategies. She has mentored students and researchers in projects analyzing social media's role in health promotion, digital privacy, and community-academic partnerships.

• New Media Technologies
• Psychosocial Impacts
• Health Communication
• +3 more

Lindsey Draper, MD serves as an Adjunct Instructor in the Roybal Laboratory within the Department of Medicine, Division of Hematology and Oncology at the University of California San Francisco School of Medicine. Her clinical practice focuses on the treatment of patients with recurrent ovarian cancer using systemic therapies including chemotherapy and immunotherapy, with a commitment to evaluating and offering clinical trial opportunities as part of individualized patient care. Dr. Draper completed her educational training with a B.S. in Biology from Juniata College (2010), an M.D. from the University of Maryland School of Medicine (2017), an Internal Medicine Residency at The Mount Sinai Hospital (2022), and is currently completing a Medical Oncology Fellowship at UCSF (2025-2027). Her research interests center on cancer immunotherapy, particularly T cell-based approaches for HPV-associated cancers and ovarian cancer. She investigates engineered T cell therapies targeting viral antigens in cervical and other HPV-related cancers, with a focus on overcoming treatment resistance and improving clinical outcomes through novel immunotherapeutic strategies. Her work bridges fundamental immunological mechanisms with clinical applications, emphasizing the translation of laboratory discoveries into patient treatments. Dr. Draper's publication record demonstrates consistent contributions to the field of cancer immunotherapy, with recent work focusing on TCR-engineered T cells for leukemia and HPV-associated malignancies. Her research trajectory shows increasing sophistication in T cell engineering approaches and a growing emphasis on addressing inflammatory responses and treatment resistance mechanisms. Parker Institute for Cancer Immunotherapy Early Career Research Award: Parker Scholar (2024) Gladstone-UCSF Institute of Genomic Immunology Symbiont Seed Grant for 'Antigen Discovery for Ovarian Cancer' (2024) Conquer Cancer Young Investigator Award, American Society of Clinical Oncology (2024) Women in Cancer Immunotherapy Network Leadership Institute Selected Participant, Society for Immunotherapy of Cancer (2024) Physician-Scientist Fellow, Chan Zuckerberg Biohub - San Francisco (2023-2025) As a physician-scientist, Dr. Draper maintains an active research program while providing clinical care, with particular emphasis on developing novel immunotherapies for gynecologic cancers. Her current fellowship at UCSF and multiple early-career awards indicate strong potential for continued contributions to the field of cancer immunotherapy. Dr. Draper works within the Roybal Laboratory at UCSF, which focuses on innovative approaches to cancer immunotherapy and T cell engineering. Her research intersects with multiple collaborative initiatives at UCSF, including the Parker Institute for Cancer Immunotherapy and the Gladstone-UCSF Institute of Genomic Immunology.

• Cancer Immunotherapy
• Ovarian Cancer
• HPV-Associated Cancers
• +5 more

Todd A. Alonzo is a Professor of Research in the Department of Preventive Medicine at the University of Southern California . As Group Statistician for the Children's Oncology Group , he focuses on statistical methods for biomarker analysis, medical diagnostic testing, and clinical trial design in pediatric acute myeloid leukemia (AML). Education: B.S. in Statistics, California State Polytechnic University (1994) MS and PhD in Biostatistics, University of Washington (1997, 2000) Research Interests include: Development of statistical frameworks for diagnostic accuracy Genomic and proteomic profiling in AML Pharmacogenomic score systems for chemotherapy response Non-inferiority trial design in low-event-rate settings Health disparities in pediatric oncology Scientific Awards : Fellow, American Statistical Association (2018) Outstanding Teacher Award, International Society for Magnetic Resonance in Medicine (2017) NIH Predoctoral Cardiovascular Biostatistics Training Grant (1995) ENAR Biometrics Society Distinguished Student Paper Award (1999) WNAR Biometrics Society Best Student Oral Presentation (1999) Leadership & Service includes editorial board memberships (Biometrics, Pediatric Blood & Cancer, Biometrical Journal), reviewer for 30+ scientific journals, and roles on multiple Data Safety and Monitoring Boards. He served as President of the International Biometric Society Western Northern America Region (WNAR) in 2009.

• Statistical Methods in Biomedical Research
• Biomarker Analysis
• Clinical Trial Design
• +7 more

Dr. Karen Anderson is a Professor at Arizona State University (ASU), affiliated with the School of Life Sciences, the Biodesign Center for Personalized Diagnostics, and the College of Health Solutions. Her research focuses on tumor biology and immune system interactions in cancer, particularly developing biomarkers for early detection of cancers like breast, ovarian, pancreatic, and HPV-related cancers. She employs molecular techniques such as protein arrays, next-gen sequencing, and functional genomics to identify therapeutic targets and vaccine candidates. Education: Ph.D. in Microbiology and Immunology (Duke University), M.D. from Duke University School of Medicine, and B.A. in Chemistry (University of Virginia). Research interests include cancer immunotherapy, autoantibody profiling, and translational applications of proteomics. Key achievements include pioneering autoantibody-based biomarker assays and investigating HPV serology in head and neck cancers. Awards include the Health Care Heroes Award and recognition as one of Arizona's Most Influential Women. Teaching responsibilities include courses on research techniques and honors thesis supervision. Grants span biomarker validation, cancer genomics, and point-of-care diagnostics. Active in professional service, including roles in grant review panels and public health initiatives.

• Cancer Research
• Immunology
• Oncology
• +3 more

Dr. Charlotte Kuperwasser is a distinguished Professor in the Department of Developmental, Molecular, and Chemical Biology at Tufts University School of Medicine . She directs the Tufts Convergence Laboratory and focuses on molecular mechanisms governing breast tissue development, cancer prevention, and organoid technologies. Her work integrates stem cell biology, epigenetics, and environmental influences such as endocrine disruptors. Education: Bachelor of Science (1997), University of Massachusetts Amherst PhD (2000), University of Massachusetts Amherst Jane Coffin Childs Postdoctoral Fellow (MIT/Whitehead Institute) Research Interests: Her lab develops 3D breast organoid models to study cancer initiation, microenvironmental interactions, and BRCA1-related mechanisms. Recent efforts include analyzing HPV-driven cancers via circulating tumor DNA and studying fibroblast signaling (e.g., DDR1) in tumor progression. Grants & Awards: Howard Hughes Fellowship, Merck Fellowship COG/Aventis Young Investigator Award Natalie V. Zucker Award NIH grants on V-ATPases and obesity-cancer links Professional Contributions: She chairs Tufts’ Sackler Convergence Laboratory and serves on AACR committees. Teaching includes courses on Molecular Cell Biology of Development and Cancer Genetics . Labs/Teams: Leads the Kuperwasser Lab, focusing on translational cancer research with cross-disciplinary collaborations in organoid engineering and clinical diagnostics.

• Breast Cancer Research
• Mammary Gland Biology
• Cancer Prevention
• +4 more

Dr. Richard E. Hayden is a Professor in the Department of Otolaryngology-Head and Neck Surgery at Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix, Arizona. He holds leadership roles as Associate Dean at Mayo Clinic School of Health Sciences and Education Director at the Mayo Clinic Center for Regenerative Biotherapeutics. His clinical and academic work centers on head and neck oncology, reconstructive surgery, and regenerative medicine. Dr. Hayden earned his MDCM from McGill University in 1974 and completed fellowships in Head and Neck Surgery-Oncology at M.D. Anderson Hospital and Radiation Oncology at Princess Margaret Hospital. He also holds advanced training in facial plastic surgery. His research spans head and neck cancer, microvascular and reconstructive surgery, transoral laser microsurgery, and regenerative medicine. He has pioneered techniques in flap reconstruction and contributed significantly to understanding postoperative outcomes and surgical innovations. His work emphasizes oncologic safety, functional preservation, and minimally invasive approaches. His recent publications (2018–2024) reflect a strong focus on transoral surgery, flap reconstruction (including submental and free flaps), mucosal-sparing radiation, and regenerative medicine education. Themes include surgical outcomes, reconstructive innovation, and interdisciplinary training in emerging therapies like CAR-T cells and regenerative healthcare. Dean's Award, Mayo Clinic Graduate School of Biomedical Sciences (2022) Distinguished Educator Award, Mayo Clinic Arizona (2016) Distinguished Service Award, American Academy of Otolaryngology - Head and Neck Surgery (2006) Honorary Member, German Society of Laryngology-Head and Neck Surgery (2007) Multiple Visiting Professorships and Keynote Speaker invitations Dr. Hayden has mentored numerous trainees and led major educational initiatives, including regenerative medicine and CAR-T curricula. He has held leadership positions such as Chair of Otolaryngology (2002–2014) and active roles in national societies. His research is supported by institutional affiliations and collaborative grants, particularly in regenerative biotherapeutics. He is involved in multiple labs and teams focused on head and neck reconstruction, surgical innovation, and regenerative medicine translation.

• Head and Neck Surgery
• Head and Neck Oncology
• Endocrine Surgery
• +7 more

Karen S. Anderson, M.D., Ph.D. is a Professor of Medicine at Mayo Clinic in Phoenix, Arizona, where she serves as a Contract Physician in the Division of Hematology/Oncology within the Department of Internal Medicine. Her clinical practice focuses on breast cancer, and she is affiliated with the Mayo Clinic Comprehensive Cancer Center and the Breast Clinic. As an active researcher, Dr. Anderson leads clinical trials in breast cancer immunotherapy and biomarker development. Dr. Anderson's educational background includes: Medical Scientist Training Program (MD), Duke University School of Medicine (1994) Ph.D. in Microbiology and Immunology, Duke University (1994) BA in Chemistry, University of Virginia (1986) Internship and Residency in Internal Medicine, Brigham and Women's Hospital, Boston Fellowship in Adult Hematology and Oncology, Dana Farber Cancer Institute Dr. Anderson's research focuses on cancer immunology with particular emphasis on breast cancer biomarkers, ovarian cancer biomarkers, pancreatic cancer biomarkers, cancer vaccines, and HPV-related cancers. Her work spans from basic immunology to clinical applications, with a strong focus on translating laboratory findings into clinical practice. She has developed innovative approaches for early cancer detection and has been instrumental in advancing breast cancer immunotherapy through clinical trials. Analysis of Dr. Anderson's recent publications reveals a consistent focus on breast cancer immunology, biomarker discovery, and HPV-related cancers. Her work integrates molecular biology, immunology, and clinical oncology to develop novel diagnostic and therapeutic approaches. Notably, her research has expanded to include computational approaches for neoantigen prediction and has addressed public health challenges including HPV-related cancer screening and even COVID-19 vaccine strategies. Dr. Anderson has received several prestigious awards: Outstanding Faculty Mentor Arizona State University Faculty Women's Association (2020) Chief Resident West Roxbury VA Hospital (1996) Phi Beta Kappa University of Virginia (1986) Merck Scholar (1986) Alpha Omega Alpha Honor Medical Society (1986) Echols Scholar University of Virginia (1982) Dr. Anderson has been actively involved in mentoring students and early-career researchers, serving on numerous thesis committees at Arizona State University across multiple departments including Molecular and Cellular Biology, Chemistry, and the Barrett Honors College. Her research is supported by multiple grants from the National Cancer Institute, including her role as Co-Chair of the Breast and Gynecologic Cancers Collaborative Group within the Early Detection Research Network. Dr. Anderson is a key member of the Arizona Biomarker Alliance Executive Committee and has established collaborative research teams focused on cancer biomarker discovery and validation. Her laboratory work integrates protein microarray technology, immunology, and cancer genomics to develop novel diagnostic and therapeutic approaches for breast and HPV-related cancers.

• Cancer Immunology
• Breast Cancer
• HPV-related Cancers
• +5 more

David J. Moore, Ph.D., is a licensed clinical psychologist and Professor of Psychiatry at UC San Diego Health. He co-directs the SDSU/UCSD Joint Doctoral Program (JDP) in Clinical Psychology and leads research at the HIV Neurobehavioral Research Program (HNRP). His work focuses on neurocognitive impairments in individuals with HIV, comorbid mental illness, and substance use disorders, with a special emphasis on technological interventions for medication adherence. Doctorate: Ph.D. in Clinical Psychology (SDSU/UCSD JDP, neuropsychology specialization) Postdoctoral Fellowship: UCSD (serious mental illness) Clinical Internship: West Los Angeles VA Dr. Moore’s research addresses: Neurocognitive complications of HIV infection Intersection of HIV and aging Technological interventions for medication adherence Impact of comorbid psychiatric/substance use disorders on functioning His publications span topics including HIV neurocognitive profiles, syndemic factors in sexual risk behavior, and aging with HIV. Current studies integrate metabolomics, neuroimaging, and behavioral data through NIH-funded grants.

• Neuropsychology
• HIV Neurobehavioral Research
• Neurocognitive Disorders
• +5 more

Dr. Chad J. Brenner is an Associate Professor in the Department of Otolaryngology-Head and Neck Surgery and Pharmacology at the University of Michigan Medical School. He also directs the U-M Program in Cellular and Molecular Biology, the Otolaryngology Clinical Laboratory (CLIA), and the Head & Neck Oncology Program. His research focuses on developing liquid biopsy tools for cancer detection and precision therapy, particularly in HPV-driven head and neck cancers. Key roles include membership in the Rogel Cancer Center, Kresge Hearing Research Institute, and Center for Computational Medicine & Bioinformatics. Education: B.S. in Biomedical Engineering, M.S. in Bioelectrical Engineering, and Ph.D. in Cellular and Molecular Biology from the University of Michigan, with doctoral work on prostate cancer mechanisms. Research Interests: HPV integration and cancer heterogeneity Urine- and blood-based liquid biopsies for real-time cancer monitoring Combination immunotherapy strategies for improving checkpoint inhibitor responses Genetic engineering to identify cancer vulnerabilities Clinical trial innovation for adaptive therapies Recent Work Highlights: Development of the MyHPVscore blood test for HPV-related head and neck cancer detection, and exploration of tumor-immune interactions through PD-L1 and T-cell profiling. Ongoing projects include PET-guided radiotherapy optimization and multi-omics analyses of tumor heterogeneity. Labs & Teams: Leads the Michigan Otolaryngology and Translational Oncology (MiOTO) lab and collaborates with interdisciplinary teams across computational medicine, immunology, and clinical oncology.

• Head and Neck Cancer
• HPV-Driven Oncogenesis
• Liquid Biopsy Technologies
• +5 more

Xin Lu is the John M. and Mary Jo Boler Collegiate Associate Professor in the Department of Biological Sciences at the University of Notre Dame. She is a full member of the Harper Cancer Research Institute (HCRI), the Boler-Parseghian Center for Rare and Neglected Diseases (CRND), and the Tumor Microenvironment and Metastasis Program at the Indiana University Simon Comprehensive Cancer Center. Her research spans tumor immunology, immunotherapy, metastasis, and multi-omics, with a focus on prostate, breast, and rare cancers. Ph.D. in Molecular Biology, Princeton University (2004–2010) B.S. in Biological Sciences, Tsinghua University, China (2000–2004) Postdoctoral Fellow, Dana-Farber Cancer Institute and M.D. Anderson Cancer Center (2010–2016) Assistant to Associate Professor, University of Notre Dame (2017–Present) Dr. Lu's research investigates the molecular and cellular mechanisms of tumor-immune crosstalk, particularly the role of myeloid-derived suppressor cells (MDSCs) and neutrophils in promoting immunotherapy resistance. Her lab uses genetically engineered mouse models, functional genomics, single-cell and spatial transcriptomics, and high-throughput screening to uncover novel therapeutic targets. A major focus is on how cancer-cell-intrinsic oncogenic signaling shapes the immunosuppressive tumor microenvironment. Her recent publications reveal mechanisms such as Acod1-mediated ferroptosis resistance in neutrophils, Pygo2-driven immunosuppression in prostate cancer, and the efficacy of ketogenic diets in overcoming checkpoint blockade resistance. These studies span multiple disciplines including cancer biology, immunology, metabolism, epigenetics, and bioengineering, reflecting a highly integrative approach to immuno-oncology. Jane Coffin Childs Postdoctoral Fellow John M. and Mary Jo Boler Faculty Appointment Cluster Chair, Cellular & Molecular Biology, IBMS PhD Program Junior Chair, Boler-Parseghian Center for Rare and Neglected Diseases Dr. Lu mentors a diverse team of graduate students, postdoctoral fellows, and undergraduates. Her lab is actively recruiting and has secured funding from federal agencies and private foundations. She collaborates with chemists, bioengineers, and bioinformaticians to develop novel therapeutics, including antibody-drug conjugates, CAR-NK cells, and small-molecule inhibitors. Her lab also develops innovative platforms like mini-tumor chips for immunotherapy evaluation. Her lab maintains affiliations with multiple interdisciplinary centers including the Warren Family Center for Drug Discovery, Eck Institute for Global Health, and Berthiaume Institute for Precision Health, underscoring her collaborative and translational research vision.

• Cancer Biology
• Tumor Microenvironment
• Tumor Immunology and Immunotherapy
• +12 more

Dr. Stephanie B. Wheeler is the Michael S. O’Malley Distinguished Professor in the Department of Health Policy and Management at the UNC Gillings School of Global Public Health. She serves as Associate Director of Community Outreach and Engagement at the UNC Lineberger Comprehensive Cancer Center and a Research Fellow at the UNC Center for Health Promotion and Disease Prevention. Her research focuses on cancer care delivery, health disparities, and systems science, with expertise in economic evaluation, simulation modeling, and large dataset analysis. Education: BA (Honors) in Theatre, College of Charleston, 2003 BS (Honors) in Biology, College of Charleston, 2003 MPH in Public Health and Family Medicine, University of Cape Town, 2007 PhD in Health Policy and Management, UNC-CH, 2010 Research Interests: Dr. Wheeler’s work addresses healthcare access, quality, value, and equity, particularly in cancer care. She uses methods like comparative effectiveness research, systems modeling, and 'big data' analytics to study cancer screening implementation, financial toxicity, and health policy interventions. Her projects are funded by NCI, the American Cancer Society, and CDC. Key Leadership Roles: Director of the Office of Community Outreach and Engagement, UNC Lineberger PI of the CDC-funded Cancer Prevention and Control Research Network Coordinating Center Co-Director of the NCI-funded T32 Cancer Care Quality Training Program Associate Editor, Journal of Clinical Oncology Awards: 2017 Hettleman Prize for Scholarly and Artistic Achievement 2017 ASPPH Early Career Award Grants & Projects: Leads/co-leads studies on colorectal cancer screening, financial navigation interventions, HPV vaccine communication, and cancer care quality surveillance. Her work emphasizes reducing disparities in rural and urban settings through evidence-based strategies. Labs & Teams: Active in the Gillings Innovation Labs and part of the Lineberger Equity Council, focusing on community-engaged research and policy translation.

• Cancer
• Health disparities/health equity
• Social epidemiology
• +5 more

Dr. Alessandro D. Santin is a Professor at the Yale School of Medicine within the Department of Obstetrics, Gynecology & Reproductive Sciences . He serves as Clinical Research Team Leader for Gynecologic Oncology at the Yale Cancer Center and co-chief of the Section of Gynecologic Oncology. Graduated magna cum laude from the University of Brescia, Italy Completed fellowships at the University of California, Irvine and University of Arkansas for Medical Sciences Dr. Santin's research bridges tumor immunology and translational oncology, focusing on: Immunotherapy for chemotherapy-resistant gynecologic cancers Therapeutic HPV vaccines for genital tumors Monoclonal antibody development Angiogenesis and radiation biology His recent publications highlight advancements in: VEGF/VEGFR2 system targeting for ovarian cancer Personalized medicine approaches with biomarkers Microsatellite instability in endometrial cancer immunotherapy Antibody-drug conjugates for uterine serous carcinoma NAC supplementation in post-COVID gynecologic patients Scientific Awards: American Association young investigator award Italian Society of Gynecologic Oncologists award for translational science Dr. Santin's lab (Laboratory for Surgery, Obstetrics & Gynecology) at Yale collaborates extensively, with 50+ postdoctoral fellows mentored. Current grants include NIH funding for Clostridium Perfringens Enterotoxin as a novel ovarian cancer therapy and leadership in multiple Gynecologic Oncology Group trials.

• Gynecologic Oncology
• Cancer Immunotherapy
• Tumor Immunology
• +7 more

Maria F. Gonzalez, MD, is an Associate Professor in the Department of Pathology and Laboratory Medicine at the Lewis Katz School of Medicine, Temple University. She also serves as Program Director of the Pathology Residency Program, playing a key role in graduate medical education. Educational Background: MD, Universidad Libre, Colombia Residency, Pathology, Baystate Medical Center/Tufts University School of Medicine, Springfield, MA Residency, Pathology, Texas Tech University-Health Sciences Center, Lubbock, TX Fellowship, Surgical Pathology, Hartford Hospital, Hartford, CT Fellowship, Cytopathology, University of Pennsylvania, Philadelphia, PA Her clinical and research interests focus on diagnostic and molecular aspects of cytopathology and surgical pathology, particularly in head and neck, gastrointestinal, and pancreatobiliary tumors. She has a special interest in HPV-mediated carcinogenesis and racial disparities in cancer pathology, contributing to equity-focused diagnostic practices. Dr. Gonzalez is board certified by the American Board of Pathology in Anatomic Pathology and Cytopathology. She is an active member of several leading professional organizations, including the College of American Pathologists (CAP), American Society of Cytology (ASC), American Society of Clinical Pathology (ASCP), United States and Canadian Academy of Pathology (USCAP), and the North American Society of Head and Neck Pathology (NASHNP). She maintains clinical practice at multiple sites, including Temple University Hospital - Main Campus, Temple University Hospital - Jeanes Campus, and Fox Chase Cancer Center, all in Philadelphia, PA. There are no listed scientific awards or publications in the provided text. However, her leadership in residency training suggests a strong commitment to medical education and mentorship, though no specific students are named.

• Cytopathology
• Surgical Pathology
• Head and Neck Pathology
• +7 more

Steven B. Smith is the Alfred Cowles Professor of Political Science at Yale University, where he has taught since 1984. His academic career includes leadership roles such as Director of Graduate Studies in Political Science, Director of the Special Program in the Humanities, and Acting Chair of Judaic Studies. Research focuses on the history of political philosophy Special attention to the ancients vs. moderns, religion and politics, and theories of representative government The 14 listed publications span 2014-2025 and include topics in pathology, oncology, and medical diagnostics, though their relevance to Smith's political science expertise remains unclear. His teaching includes the acclaimed course Introduction to Political Philosophy , and he has received awards such as the Lex Hixon '63 Prize for Teaching Excellence (2009). Ralph Waldo Emerson Prize from Phi Beta Kappa Lex Hixon '63 Prize for Teaching Excellence (2009)

• Political Philosophy
• History of Political Thought
• Ancients vs. Moderns
• +3 more

Dr. Marla Keller is a tenured Professor of Medicine and Obstetrics & Gynecology at Albert Einstein College of Medicine, currently serving as Executive Dean and holder of the Jacob and Jeanne Barkey Chair in Medicine. Director, NIH-funded Harold and Muriel Block Institute for Clinical and Translational Research Interim Senior Associate Dean for Clinical and Translational Research Vice Chair of Research for Department of Medicine Dr. Keller's research focuses on: Biomedical HIV prevention strategies Vaginal microbicide development PrEP implementation in women Cervical cancer screening in HIV+ women Immune responses to SARS-CoV-2 COVID-19 clinical trials Her recent publications emphasize: HPV infection and cervical precancer Vaginal microbiome interactions PrEP delivery systems HIV/HSV coinfection dynamics Convalescent plasma therapy Metronidazole treatment response Key scientific awards include: Infectious Disease Mentoring Award (2013) COVID-19 Distinguished Service Award (2021) Spirit of Achievement Changemaker Award (2023) New York Super Doctor (2011-2015)

• HIV Prevention in Women
• Vaginal Microbicides
• Pre-Exposure Prophylaxis (PrEP)
• +4 more